{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:38:42Z","timestamp":1793176722401,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jneuroim.2026.579111","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:52:35Z","timestamp":1791820355000},"page":"579111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Co-occurrence of myasthenia gravis and neuromyelitis optica spectrum disorder: A case series and literature review"],"prefix":"10.1016","volume":"422","author":[{"given":"Natalia","family":"G\u00f3mez-Salazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Andrea","family":"Ort\u00edz-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Jim\u00e9nez-Tocasuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alexander","family":"Granados-Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold Styven","family":"Basallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neiry Mar\u00eda","family":"Zapa-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gaviria-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579111_bb0005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1212\/01.WNL.0000115168.73299.88","article-title":"Devic disease and thymoma with anti-central nervous system and antithymus antibodies","volume":"62","author":"Antoine","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0010","article-title":"Neuromyelitis optica and myasthenia gravis in a young Nigerian girl","author":"Balarabe","year":"2015","journal-title":"Case Rep."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102205","article-title":"Anti-MOG and anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis","volume":"44","author":"Bates","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.msard.2018.12.028","article-title":"Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases","volume":"28","author":"Bibic","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0004-282X2008000100002","article-title":"Demyelinating disease in patients with myasthenia gravis","volume":"66","author":"Bichuetti","year":"2008","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102173","article-title":"Neuromyelitis optica in patients with myasthenia gravis: two case-reports","volume":"43","author":"Castro-Suarez","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000334128","article-title":"Myasthenia gravis during the course of Neuromyelitis Optica","volume":"3","author":"Etemadifar","year":"2011","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2006.01392.x","article-title":"Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population","volume":"13","author":"Furukawa","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0045","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0091-6749(99)70431-8","article-title":"Long-term immunologic effects of thymectomy in patients with myasthenia gravis","volume":"103","author":"Gerli","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0050","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1212\/01.wnl.0000234142.41728.a0","article-title":"Occurrence of CNS demyelinating disease in patients with myasthenia gravis","volume":"67","author":"Gotkine","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clineuro.2014.07.036","article-title":"Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature","volume":"125","author":"Ikeguchi","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1191\/1352458503ms964oa","article-title":"Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia","volume":"9","author":"Isbister","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1352458511431728","article-title":"Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature","volume":"18","author":"Jarius","year":"2012","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0070","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209482","article-title":"Does surgical removal of the thymus have deleterious consequences?","volume":"102","author":"Kaminski","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2008.06.038","article-title":"NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy","volume":"275","author":"Kay","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0080","article-title":"Understanding sex differences in autoimmune diseases: immunologic mechanisms","volume":"26","author":"Kim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archneur.63.6.851","article-title":"Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy","volume":"63","author":"Kister","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5692\/clinicalneurol.50.111","article-title":"A case of subacute myelitis with anti-aquaporin 4 antibody after thymectomy for myasthenia gravis: review of autoimmune diseases after thymectomy","volume":"50","author":"Kohsaka","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2302892","article-title":"Health consequences of Thymus removal in adults","volume":"389","author":"Kooshesh","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0100","doi-asserted-by":"crossref","first-page":"980","DOI":"10.12998\/wjcc.v3.i12.980","article-title":"Myasthenia gravis and thymic neoplasms: a brief review","volume":"3","author":"Kumar","year":"2015","journal-title":"WJCC"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0105","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0110","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s10072-023-07163-3","article-title":"Myasthenia gravis and five autoimmune diseases: a bidirectional Mendelian randomization study","volume":"45","author":"Li","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105848","article-title":"Polyautoimmunity and multiple autoimmune syndrome in patients with neuromyelitis optica spectrum disorder","volume":"90","author":"Lopes","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/13524585070130030201","article-title":"Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands","volume":"13","author":"Nakamura","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/NRL.0b013e318247bc91","article-title":"Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis","volume":"18","author":"Ogaki","year":"2012","journal-title":"Neurologist"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nrl.2020.02.008","article-title":"Copresence of myasthenia gravis and neuromyelitis optica: 2 case reports","volume":"36","author":"Pi\u00f1ar Morales","year":"2021","journal-title":"Neurologia (Engl Ed)"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0135","article-title":"B-cell-activating factor and autoimmune myasthenia gravis","volume":"2011","author":"Ragheb","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0404.2005.00374.x","article-title":"Myasthenia gravis: clinical, immunological, and therapeutic advances","volume":"111","author":"Romi","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1528989","article-title":"Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review","volume":"15","author":"Song","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.msard.2013.01.003","article-title":"Myasthenia gravis and neuromyelitis opica: a causal link","volume":"2","author":"Spillane","year":"2013","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2006.05.023","article-title":"The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis","volume":"178","author":"Thangarajh","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5692\/clinicalneurol.52.503","article-title":"Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report","volume":"52","author":"Tsujii","year":"2012","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2009.08.040","article-title":"Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis","volume":"287","author":"Uzawa","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01785","article-title":"Immunopathogenesis in myasthenia gravis and neuromyelitis optica","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579111_bb0180","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/01.wnl.0000262954.51568.25","article-title":"Occurrence of CNS demyelinating disease in patients with myasthenia gravis","volume":"68","author":"Weinshenker","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/01658107.2013.879903","article-title":"Neuromyelitis Optica Spectrum disorder in a Chinese woman with ocular myasthenia gravis: first reported case in the Chinese population","volume":"38","author":"Yau","year":"2014","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.jneuroim.2026.579111_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223322","article-title":"Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:23:14Z","timestamp":1793175794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":38,"alternative-id":["S0165572826002602"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579111","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-occurrence of myasthenia gravis and neuromyelitis optica spectrum disorder: A case series and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"579111"}}